Cargando…

SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway

A ginsenoside F2-enhanced mixture (SGL 121) increases the content of ginsenoside F2 by biotransformation. In the present study, we investigated the effect of SGL 121 on nonalcoholic fatty liver disease (NAFLD) in vitro and in vivo. High-fat, high-carbohydrate-diet (HFHC)-fed mice were administered S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Da Eun, Chang, Bo Yoon, Jeon, Byeong Min, Baek, Jong In, Kim, Sun Chang, Kim, Sung Yeon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352188/ https://www.ncbi.nlm.nih.gov/pubmed/32630596 http://dx.doi.org/10.3390/ijms21124534

Ejemplares similares

Liraglutide Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism via SHP1/AMPK Signaling Pathway
por: Yu, Peng, et al.
Publicado: (2019)

Tricin-enriched Zizania latifolia ameliorates non-alcoholic fatty liver disease through AMPK-dependent pathways
por: Chang, Bo Yoon, et al.
Publicado: (2023)

Asprosin contributes to nonalcoholic fatty liver disease through regulating lipid accumulation and inflammatory response via AMPK signaling
por: Zhang, Bo, et al.
Publicado: (2023)

MicroRNA regulation of AMPK in nonalcoholic fatty liver disease
por: Sun, Hao, et al.
Publicado: (2023)

Aspirin Improves Nonalcoholic Fatty Liver Disease and Atherosclerosis through Regulation of the PPARδ-AMPK-PGC-1α Pathway in Dyslipidemic Conditions
por: Han, Yoon-Mi, et al.
Publicado: (2020)

Evaluation of the severity of nonalcoholic fatty liver disease through analysis of serum exosomal miRNA expression
por: Gim, Jeong-An, et al.
Publicado: (2021)

MicroRNA-137-3p Improves Nonalcoholic Fatty Liver Disease through Activating AMPKα
por: Yu, Yuanjie, et al.
Publicado: (2021)

Antiresistin RNA Oligonucleotide Ameliorates Diet-Induced Nonalcoholic Fatty Liver Disease in Mice through Attenuating Proinflammatory Cytokines
por: Tan, Yi, et al.
Publicado: (2015)

The Effect of Lactobacillus salivarius SGL03 on Clinical and Microbiological Parameters in Periodontal Patients
por: NĘDZI-GÓRA, MAŁGORZATA, et al.
Publicado: (2020)

Kahweol inhibits lipid accumulation and induces Glucose-uptake through activation of AMP-activated protein kinase (AMPK)
por: Baek, Jung-Hwan, et al.
Publicado: (2017)

Assessment of the inter-platform reproducibility of ultrasound attenuation examination in nonalcoholic fatty liver disease
por: Jeon, Sun Kyung, et al.
Publicado: (2022)

Lipid Accumulation in HepG2 Cells Is Attenuated by Strawberry Extract through AMPK Activation
por: Forbes-Hernández, Tamara Y., et al.
Publicado: (2017)

Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
por: Lee, Na Young, et al.
Publicado: (2021)

Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis
por: Yoon, Sang Jun, et al.
Publicado: (2023)

Methyl Brevifolincarboxylate Attenuates Free Fatty Acid-Induced Lipid Metabolism and Inflammation in Hepatocytes through AMPK/NF-κB Signaling Pathway
por: Geethangili, Madamanchi, et al.
Publicado: (2021)

Thrap3 promotes nonalcoholic fatty liver disease by suppressing AMPK-mediated autophagy
por: Jang, Hyun-Jun, et al.
Publicado: (2023)

Fucoxanthin Attenuates Free Fatty Acid-Induced Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism/Oxidative Stress/Inflammation via the AMPK/Nrf2/TLR4 Signaling Pathway
por: Ye, Jiena, et al.
Publicado: (2022)

LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway
por: Chen, Xue-Yang, et al.
Publicado: (2019)

Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease
por: Kim, Tae Hyung, et al.
Publicado: (2021)

LY6D is crucial for lipid accumulation and inflammation in nonalcoholic fatty liver disease
por: Lee, Jibeom, et al.
Publicado: (2023)

FRI037 Time-restricted Feeding Prevents Progression Of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Through IPMK
por: Jung, Ik-Rak, et al.
Publicado: (2023)

Omega-3 Fatty Acids Attenuate Renal Fibrosis via AMPK-Mediated Autophagy Flux Activation
por: Han, Suyeon, et al.
Publicado: (2023)

Critical Intersectionality, Ageism, and Intergenerational Supports Foregrounding Black SGL and Gay Older Men
por: Perone, Angela, et al.
Publicado: (2020)

Triglyceride-Glucose Index for Early Prediction of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of 121,975 Individuals
por: Beran, Azizullah, et al.
Publicado: (2022)

Circ_0057558 promotes nonalcoholic fatty liver disease by regulating ROCK1/AMPK signaling through targeting miR-206
por: Chen, Xi, et al.
Publicado: (2021)

Aurantio-Obtusin Attenuates Non-Alcoholic Fatty Liver Disease Through AMPK-Mediated Autophagy and Fatty Acid Oxidation Pathways
por: Zhou, Fei, et al.
Publicado: (2022)

PACAP attenuates hepatic lipid accumulation through the FAIM/AMPK/IRβ axis during overnutrition
por: Luo, Wei, et al.
Publicado: (2022)

Fimasartan Ameliorates Nonalcoholic Fatty Liver Disease through PPARδ Regulation in Hyperlipidemic and Hypertensive Conditions
por: Lee, Yong-Jik, et al.
Publicado: (2017)

A Novel Identified Peptide Hormone “Metabolitin” Attenuates Lipid Absorption in the Small Intestine of Diabetic Mice with Nonalcoholic Fatty Liver Disease by Regulating Neurotensin and AMPK Signaling Pathway
por: Xu, Peng, et al.
Publicado: (2021)

Omega-3 polyunsaturated fatty acid and ursodeoxycholic acid have an additive effect in attenuating diet-induced nonalcoholic steatohepatitis in mice
por: Kim, Ja Kyung, et al.
Publicado: (2014)

Regulation of Butyrate-Induced Resistance through AMPK Signaling Pathway in Human Colon Cancer Cells
por: Yoo, Hee Young, et al.
Publicado: (2021)

Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease
por: Kim, Young Seok, et al.
Publicado: (2013)

Multiparametric MR Is a Valuable Modality for Evaluating Disease Severity of Nonalcoholic Fatty Liver Disease
por: Lee, Young-Sun, et al.
Publicado: (2020)

Association of nonalcoholic fatty liver disease and venous thromboembolic disease in healthy adults in Korea: a nationwide study
por: Kim, Chang-Yeon, et al.
Publicado: (2023)

Curcumin Ameliorates Nonalcoholic Fatty Liver Disease through Inhibition of O-GlcNAcylation
por: Lee, Da Eun, et al.
Publicado: (2019)

Role of Sterylglucosidase 1 (Sgl1) on the pathogenicity of Cryptococcus neoformans: potential applications for vaccine development
por: Rella, Antonella, et al.
Publicado: (2015)

Draft Genome Sequence of Lactobacillus salivarius SGL 03, a Novel Potential Probiotic Strain
por: Federici, Federica, et al.
Publicado: (2017)

Salidroside Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease via AMPK-Dependent TXNIP/NLRP3 Pathway
por: Zheng, Tao, et al.
Publicado: (2018)

A High-Fat Diet Attenuates AMPK α1 in Adipocytes to Induce Exosome Shedding and Nonalcoholic Fatty Liver Development In Vivo
por: Yan, Chenghui, et al.
Publicado: (2021)

Inhibition of Adipogenesis by Diphlorethohydroxycarmalol (DPHC) through AMPK Activation in Adipocytes
por: Kang, Min-Cheol, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jb5mfmd3q7o41eeqf0o6a228da